ArticleGenome biology2026
O-GlcNAcylation of NONO mediates alternative splicing of SETMAR and facilitates NHEJ repair.
Article in Genome biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Review
- αS-SETMAR: Inducing Protective Chaos in Glioblastoma?Cancers · 2026Article
- Post-translational modification in hepatocellular carcinoma resistance: molecular mechanisms and therapeutic targeting.Frontiers in immunology · 2026Review
- CAF-derived exosomal circMPP6 drives ovarian cancer metastasis by coordinating nuclear and cytoplasmic regulation of ADAM22 to activate TGF-β/Smad signaling.International journal of biological sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundThe NONO protein plays a crucial role in RNA metabolism and DNA repair. It undergoes various post-translational modifications, including phosphorylation, ubiquitination, acetylation and methylation, all of which regulate its diverse cellular functions. However, the role of O-GlcNAcylation in regulating NONO's function in DNA damage repair is not well understood.
resultsThis study demonstrates that O-GlcNAcylation of NONO at Serine 147 (Ser147) is essential for its recruitment to DNA damage sites. Specifically, O-GlcNAcylation at Ser147 reduces NONO ubiquitination and stabilizes its interaction with SFPQ, regulating the alternative splicing of the histone methyltransferase SETMAR. A deficiency in O-GlcNAcylation at Ser 147 impairs NONO's binding to SETMAR pre-mRNA, leading to an increased production of the truncated isoform of SETMAR (SETMAR-S). The resulting SETMAR-S suppresses the generation of H3K36me2 and inhibits the recruitment of Ku70 at DNA damage sites, ultimately impairing non-homologous end joining (NHEJ) repair. Furthermore, the disruption of O-GlcNAcylation at Ser147 sensitizes liver cancer cells to ionizing radiation treatment, both in vitro and in vivo.
conclusionsO-GlcNAcylation at Ser 147 of NONO mediates the alternative splicing of SETMAR and facilitates NHEJ repair. Collectively, our findings suggest that targeting NONO O-GlcNAcylation may provide a novel therapeutic strategy for cancer treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.